Ex Vivo Culture of Cells Derived From Circulating Tumour Cell Xenograft to support Small Cell Lung Cancer Research and Experimental Therapeutics
Conclusion and ImplicationsShort term cultures of CDX provide a tractable platform to screen new treatments, identify predictive and pharmacodynamic biomarkers and interrogate mechanisms of resistance to better understand progression of this recalcitrant tumour.
Source: British Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Alice Lallo,
Sakshi Gulati,
Maximilian W Schenk,
Garima Khandelwal,
Ulrika Warpman Berglund,
Ioannis S Pateras,
Christopher P E Chester,
Therese M Pham,
Christina Kalderen,
Kristopher K Frese,
Vassilis G Gorgoulis,
Crispin Miller,
Fiona Blackh Tags: RESEARCH PAPER Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Genetics | Lung Cancer | Neurology | Pathology | Small Cell Lung Cancer | UK Health